Adamis Pharmaceuticals Corporation Gains 40.6%

Thu, Aug 03, 2023 at 07:34 PM
Adamis Pharmaceuticals Corporation Gains 40.6%

Adamis Pharmaceuticals Corporation (ADMP:NASDAQ) rocketted at $1.87, a gain of 40.6%. The stock appeared on our News Catalysts scanner on Wed, Aug 02, 2023 at 09:05 AM in the 'PUBLIC OFFERING' category. From Thu, Jul 20, 2023, the stock recorded 50.00% Up Days and 63.64% Green Days

The stock spiked on Tue, Aug 01, 2023 at $8.28 with a volume of 20M+.

About Adamis Pharmaceuticals Corporation (ADMP:NASDAQ)

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.